Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04840563 · ClinicalTrials.gov registry record · NA
Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04840563 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 10 participants.
The verdict
NCT04840563, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Approximately 10 habitual soft contact lens wearing participants will be enrolled in this bilateral, randomized, double-masked (participant and investigator masked) repeated measures insertion study. All participants will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If participants satisfy all eligibility criteria and none of the exclusion criteria, participants will insert study lenses in random, successive order according to unique randomization schedules that will be provided to each Investigator.
Interventions
- DEVICE Kalifon A
- DEVICE Dailies Total1
- DEVICE Precision1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-04-07 |
| Est. Completion | 2021-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04840563
The ClinicalTrials.gov registry entry for NCT04840563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Kalifon A is the first listed.
NCT04840563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04840563 about?
NCT04840563 is a clinical study titled "Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1". Approximately 10 habitual soft contact lens wearing participants will be enrolled in this bilateral, randomized, double-masked (participant and investigator masked) repeated measures insertion study. All participants will be seen for a Screening/Dispensing Visit at which informed consent will be obt...
What is the current status of trial NCT04840563?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-04-07. Estimated completion is 2021-04-15.
What interventions are being tested in trial NCT04840563?
The interventions under investigation include: Kalifon A (DEVICE), Dailies Total1 (DEVICE), Precision1 (DEVICE).
Who is sponsoring clinical trial NCT04840563?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.